
ISS ESG InFocus: Pharmaceuticals & Biotechnology
ISS ESG’s team of specialist analysts release regular updates on the ESG risks associated with a specific industry. The InFocus reports focus on the ISS
ISS ESG’s team of specialist analysts release regular updates on the ESG risks associated with a specific industry. The InFocus reports focus on the ISS
For many, investing in the current market environment can be described as navigating uncharted waters. With US inflation running at a 40-year high and a
Below is an excerpt from ISS LiquidMetrix’s recently released paper “Do ESG Ratings Impact Stock Price Volatility?”. The full paper is available for download from the Institutional
Each month ISS ESG’s team of specialist analysts releases an update on the ESG risks associated with a specific industry sector. The InFocus reports focus
LONDON (March 3, 2022) — ISS ESG, the responsible investment arm of Institutional Shareholder Services Inc. (ISS), today announced the launch of a new online
Each month ISS ESG’s team of specialist analysts releases an update on the ESG risks associated with a specific industry sector. The InFocus reports focus
Intangible assets continue to represent a significant portion of the overall Balance Sheet globally. Over 40% of capital in the US today is in the
Below is an excerpt from ISS ESG’s thought leadership paper “The Content of Their Character: How Diversity & Inclusion Continue to Drive Change”. The full
Below is an excerpt from ISS ESG’s recently released “The Screened and Prime Series: ESG Attributes and Market Returns During the Pandemic.” The full paper
In the wake of hundreds of lawsuits over deadly wildfires in California, and with potential liabilities amounting to an estimated USD 30 billion, PG&E Corp.